Tubulis GmbHAcquisitionGilead acquires German ADC specialist Tubulis in US$5bn dealFor Tubulis, the time for an exit has arrived: US based pharma group Gilead is set to pay up to US$5bn for the biotech’s ADC expertise. more ➔
VanessaSpencer - stock.adobe.comBiotech ClusterPortugal’s biotech industry is growing upFor years, Portugal sat just outside Europe’s main biotech conversation: scientifically credible, strong in research, but too small, too fragmented and too thinly financed to compete with the established … more ➔
EyEM, Freepik.comDenmarkThe rollercoaster ride stopps and danish IO Biotech goes bustThe Copenhagen-based cancer immunotherapy company IO Biotech has come to an abrupt end, marking one of the more sobering recent failures in Europe’s mid-cap biotech segment. Founded in 2019, the company … more ➔
GenerareArtificial intelligenceFrench AI: 20 million funding for Generare to find better data in natureFrench Generare, founded in 2023, is positioning itself at the intersection of synthetic biology and artificial intelligence by tackling what many in the sector now see as a fundamental bottleneck: the … more ➔
M&ALilly moves deeper into sleep medicine with up to $7.8 billion Centessa dealEli Lilly has agreed to acquire UK-based Centessa Pharmaceuticals in a deal worth up to $7.8 billion, giving the pharma giant a high-profile entry into one of biotech’s most closely watched neuroscience … more ➔
Novartis GroupSwitzerlandSomething of a shopping spree: Novartis to acquire US-based Excellergy for up to $2bnNovartis is back on the acquisition trail, agreeing to buy California-based Excellergy for up to $2bn. The antibody Exl-111 is intended to strengthen its allergy pipeline and go beyond the current standard … more ➔
Ethris GmbHVaccinationEurope’s pivotal choice: Vaccination is health securityThe COVID 19 pandemic demonstrated that Europe can move fast, take risk, and deliver world class vaccines when political will, science and capital are aligned. Treating vaccines as strategic assets, … more ➔
Kelli McClintock auf UnsplashStartups10 European Startups to watch in 2026Ten young European biotechs are heading into 2026 with the kind of momentum that can quickly turn promising science into defining data: first clinical entries, platform-to-pipeline transitions, and funding … more ➔
Ysios CapitalFundingYsios Capital launches InceptionBio: €100m for Spanish biotech spinoutsSpanish VC firm Ysios Capital has unveiled InceptionBio, a €100 million fund dedicated to boosting Spanish biotech innovation. The initiative targets company creation from top-tier research, backed … more ➔
123rf.com/Paul GrecaudFinancingEIF starts €15bn fund-of-funds for scaling European tech companiesThe European Investment Fund has launched a new fund of funds with a target volume of €15 billion to strengthen growth financing in Europe’s technology sector. The programme is considered the largest … more ➔
Tubulis GmbH
VanessaSpencer - stock.adobe.com
EyEM, Freepik.com
Generare
Novartis Group
Ethris GmbH
Kelli McClintock auf Unsplash
Ysios Capital
123rf.com/Paul Grecaud